860326

Acorda Therapeutics, Inc. — FEI 3002457563

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 19, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pearl River, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
670621 CFR 310.305(c)(1)(i)Late submission
672821 CFR 314.80(b)Failure to review ADE information